chr1:110230439:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr1:110,230,439-110,251,307 |
| hg38 | chr1:109,687,817-109,708,685 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.225 | squamous cell carcinoma | Subgroup analysis showed a significant relationship between squamous carcinoma (... | BeFree,CTD_human,GAD,LHGDN | 25036724 | Detail |
| 0.225 | squamous cell carcinoma | GSTM1 exhibited a significant association with increased risk of squamous cell c... | BeFree,CTD_human,GAD,LHGDN | 25663492 | Detail |
| 0.008 | Carcinoma, Transitional Cell | NA | BeFree,GAD | Detail | |
| 0.003 | Cardiovascular Diseases | NA | BeFree,GAD | Detail | |
| 0.007 | Neoplastic Cell Transformation | NA | GAD | Detail | |
| 0.002 | Cerebellar Neoplasms | NA | GAD | Detail | |
| 0.003 | cerebral infarction | NA | BeFree,GAD | Detail | |
| 0.005 | brain ischemia | NA | GAD | Detail | |
| 0.002 | Cerebrovascular Disorders | NA | GAD | Detail | |
| 0.005 | Malignant tumor of cervix | This study aims to investigate the clinical impact of glutathione-S-transferase ... | BeFree | 25663492 | Detail |
| 0.005 | Malignant tumor of cervix | Lack of participation of the GSTM1 polymorphism in cervical cancer development i... | BeFree | 25773790 | Detail |
| <0.001 | Cervical dysplasia | NA | BeFree | Detail | |
| 0.029 | Uterine Cervical Neoplasm | NA | BeFree,GAD | Detail | |
| <0.001 | Primary biliary cirrhosis | NA | BeFree | Detail | |
| <0.001 | cholestasis | Conversely, the expression levels of liver detoxification enzymes, UGT2B4/7, SUL... | BeFree | 25798860 | Detail |
| 0.151 | Chromosome Aberrations | NA | CTD_human,GAD | Detail | |
| 0.005 | Congenital chromosomal disease | This study was conducted to determine the association between arsenic exposure a... | BeFree | 25395496 | Detail |
| 0.005 | Chromosome Deletion | NA | GAD | Detail | |
| <0.001 | Bronchitis, Chronic | NA | BeFree | Detail | |
| 0.010 | cleft lip | NA | BeFree,GAD | Detail | |
| 0.012 | cleft palate | NA | BeFree,GAD | Detail | |
| 0.005 | Cocarcinogenesis | NA | GAD | Detail | |
| 0.006 | ulcerative colitis | NA | BeFree,GAD | Detail | |
| 0.010 | Colonic Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.014 | colorectal carcinoma | Analysis for ethnicity and smoking for each of the investigated polymorphisms sh... | BeFree | 25249451 | Detail |
| 0.014 | colorectal carcinoma | In conclusion, the GSTT1 and GSTM1 polymorphisms, but not GSTP1, may modulate th... | BeFree | 25408579 | Detail |
| 0.014 | colorectal carcinoma | Association between glutathione S-transferase M1 and T1 polymorphisms and colore... | BeFree | 25807650 | Detail |
| 0.155 | Colorectal Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.004 | Coronary Arteriosclerosis | Association between GSTM1 null genotype and coronary artery disease risk: a meta... | BeFree | 25183432 | Detail |
| 0.018 | Coronary heart disease | Association between GSTM1 null genotype and coronary artery disease risk: a meta... | BeFree,GAD | 25183432 | Detail |
| 0.003 | Crohn Disease | NA | BeFree,GAD | Detail | |
| 0.008 | cystic fibrosis | NA | BeFree,GAD | Detail | |
| 0.012 | Deafness | NA | GAD | Detail | |
| 0.002 | Hearing Loss, Sudden | NA | GAD | Detail | |
| 0.003 | Mental Depression | NA | BeFree,GAD | Detail | |
| 0.001 | depressive disorder | NA | BeFree | Detail | |
| 0.005 | Drug Eruptions | NA | BeFree,GAD,LHGDN | Detail | |
| 0.013 | Dermatitis, Atopic | NA | BeFree,GAD,LHGDN | Detail | |
| 0.001 | Diabetes | NA | BeFree | Detail | |
| 0.009 | diabetes mellitus | NA | BeFree,GAD,LHGDN | Detail | |
| 0.008 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
| 0.144 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,CTD_human,GAD | Detail | |
| 0.008 | Diabetic Nephropathy | NA | BeFree,GAD | Detail | |
| <0.001 | Diabetic Neuropathies | NA | BeFree | Detail | |
| <0.001 | diabetic retinopathy | NA | BeFree | Detail | |
| 0.078 | DNA Damage | NA | GAD | Detail | |
| 0.005 | Down syndrome | NA | GAD | Detail | |
| <0.001 | Drug abuse | NA | BeFree | Detail | |
| 0.120 | drug allergy | NA | CTD_human | Detail | |
| 0.002 | Drug toxicity | NA | GAD | Detail | |
| 0.002 | Duodenal Neoplasms | NA | GAD | Detail | |
| 0.002 | Dyskinesia, Drug-Induced | NA | GAD | Detail | |
| 0.005 | Dysmenorrhea | NA | GAD | Detail | |
| 0.002 | Dyspepsia | NA | GAD | Detail | |
| <0.001 | Dyspnea | NA | BeFree | Detail | |
| 0.003 | eclampsia | NA | BeFree,GAD | Detail | |
| <0.001 | Eczema | NA | BeFree | Detail | |
| 0.005 | Ehlers-Danlos syndrome | NA | BeFree,GAD | Detail | |
| 0.005 | Pathological accumulation of air in tissues | NA | GAD | Detail | |
| 0.002 | Endometrial Neoplasms | NA | GAD | Detail | |
| 0.040 | endometriosis | Null genotypes of GSTM1 and GSTT1 and endometriosis risk: a meta-analysis of 25 ... | BeFree,GAD,LHGDN | 25208225 | Detail |
| 0.040 | endometriosis | Glutathione S-transferase M1 polymorphism and endometriosis susceptibility: a me... | BeFree,GAD,LHGDN | 25443469 | Detail |
| 0.040 | endometriosis | Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and endomet... | BeFree,GAD,LHGDN | 25461363 | Detail |
| 0.002 | Ependymoma | NA | GAD | Detail | |
| 0.008 | epilepsy | Effects of glutathione S-transferase M1 and T1 deletions on epilepsy risk among ... | BeFree,GAD | 24970787 | Detail |
| 0.003 | esophageal atresia | NA | BeFree,GAD | Detail | |
| 0.048 | Esophageal Neoplasms | In this study, we assessed the association of functional polymorphisms in GSTM1 ... | BeFree,GAD,LHGDN | 25432134 | Detail |
| 0.005 | peptic esophagitis | NA | BeFree,GAD | Detail | |
| 0.001 | Exanthema | NA | BeFree | Detail | |
| 0.003 | Disorder of eye | NA | BeFree,GAD | Detail | |
| 0.003 | Fanconi anemia | NA | BeFree,GAD | Detail | |
| 0.002 | Fatty Liver | NA | GAD | Detail | |
| 0.002 | Fatty Liver, Alcoholic | NA | GAD | Detail | |
| 0.007 | Fetal Growth Retardation | NA | GAD | Detail | |
| 0.003 | Fibrosis | NA | LHGDN | Detail | |
| 0.002 | Flushing | NA | GAD | Detail | |
| 0.005 | gallbladder neoplasm | NA | LHGDN | Detail | |
| 0.002 | gastritis | NA | GAD | Detail | |
| <0.001 | Gastritis, Atrophic | NA | BeFree | Detail | |
| 0.005 | gastroesophageal reflux disease | NA | BeFree,GAD | Detail | |
| 0.002 | Gastrointestinal Neoplasms | NA | GAD | Detail | |
| 0.002 | Female Genital Diseases | NA | GAD | Detail | |
| 0.005 | glaucoma | The GSTM1 null genotype was more frequent in the glaucoma group than in the cont... | BeFree,GAD | 25366778 | Detail |
| <0.001 | primary angle-closure glaucoma | Is the GSTM1 null polymorphism a risk factor for primary angle-closure glaucoma ... | BeFree | 25725180 | Detail |
| 0.017 | Glaucoma, Open-Angle | NA | GAD,LHGDN | Detail | |
| 0.011 | Glioma | NA | BeFree,GAD | Detail | |
| <0.001 | Globus Hystericus | NA | BeFree | Detail | |
| 0.002 | membranous glomerulonephritis | NA | GAD | Detail | |
| 0.007 | Graft-vs-Host Disease | NA | BeFree,GAD | Detail | |
| 0.003 | Graves Disease | NA | BeFree,GAD | Detail | |
| 0.002 | Hamartoma | NA | GAD | Detail | |
| 0.064 | Head and Neck Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.012 | Hearing Loss, Partial | NA | GAD | Detail | |
| 0.002 | Hearing Loss, High-Frequency | NA | GAD | Detail | |
| 0.005 | Noise-induced hearing loss | NA | GAD | Detail | |
| 0.003 | Sensorineural Hearing Loss (disorder) | NA | BeFree,GAD | Detail | |
| 0.003 | Hematological Disease | NA | BeFree,GAD | Detail | |
| 0.003 | Hemoglobinopathies | NA | BeFree,GAD | Detail | |
| 0.003 | hepatic veno-occlusive disease | NA | BeFree,GAD | Detail | |
| 0.004 | hepatitis | NA | BeFree,LHGDN | Detail | |
| <0.001 | hepatitis A | NA | BeFree | Detail | |
| 0.010 | hepatitis B | NA | BeFree,GAD | Detail | |
| 0.003 | Hepatitis, Chronic | NA | BeFree,GAD | Detail | |
| 0.007 | Hepatitis, Toxic | NA | GAD | Detail | |
| 0.003 | hepatitis C | NA | BeFree,GAD | Detail | |
| 0.003 | HIV Infections | NA | BeFree,GAD | Detail | |
| 0.015 | Hodgkin Disease | NA | BeFree,GAD | Detail | |
| 0.005 | Hypersensitivity | NA | GAD | Detail | |
| 0.113 | Hypertensive disease | Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the r... | BeFree,GAD,LHGDN,RGD | 25742618 | Detail |
| 0.002 | Hypopharyngeal Neoplasms | NA | GAD | Detail | |
| 0.080 | Hypotension | NA | RGD | Detail | |
| <0.001 | Immune System Diseases | NA | BeFree | Detail | |
| 0.003 | infertility | NA | LHGDN | Detail | |
| 0.027 | male infertility | Glutathione S-transferase Mu-1 gene polymorphism in Egyptian patients with idiop... | BeFree,GAD | 25130880 | Detail |
| 0.027 | male infertility | Our findings also underrate the significance of the effect of GSTM1 and/or GSTT1... | BeFree,GAD | 25532576 | Detail |
| 0.012 | Inflammation | NA | GAD | Detail | |
| 0.006 | Inflammatory Bowel Diseases | NA | BeFree,GAD,LHGDN | Detail | |
| 0.006 | neonatal jaundice | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | keratosis | NA | BeFree,LHGDN | Detail | |
| 0.003 | actinic keratosis | NA | BeFree,GAD | Detail | |
| 0.003 | Kidney Diseases | NA | BeFree,GAD | Detail | |
| 0.009 | Kidney Failure, Chronic | NA | BeFree,GAD,LHGDN | Detail | |
| 0.012 | Kidney Neoplasm | NA | GAD | Detail | |
| 0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
| 0.031 | Laryngeal neoplasm | NA | GAD,LHGDN | Detail | |
| 0.003 | Fibroid Tumor | NA | BeFree,GAD | Detail | |
| <0.001 | leprosy | NA | BeFree | Detail | |
| 0.162 | leukemia | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.013 | chronic lymphocytic leukemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | lymphoid leukemia | NA | BeFree,GAD | Detail | |
| 0.006 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| 0.013 | Leukemia, Lymphocytic, Acute, L1 | Meta-analysis included 22, 10 and 20 studies examining the association of childh... | BeFree,GAD | 25102096 | Detail |
| 0.002 | Leukemia, Lymphocytic, Acute, L2 | NA | GAD | Detail | |
| 0.049 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD,LHGDN | Detail | |
| 0.017 | myeloid leukemia | NA | GAD | Detail | |
| 0.018 | Myeloid Leukemia, Chronic | Based on these findings, we find that the interaction between GSTT1 and GSTM1 se... | BeFree,GAD | 24913811 | Detail |
| 0.018 | Myeloid Leukemia, Chronic | Role of glutathione-S-transferase M1 (GSTM1) and T1 (GSTT1) genes in the develop... | BeFree,GAD | 25432281 | Detail |
| 0.002 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | GAD | Detail | |
| <0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
| <0.001 | leukopenia | NA | BeFree | Detail | |
| 0.006 | Leukoplakia | NA | BeFree,GAD | Detail | |
| 0.011 | Leukoplakia, Oral | NA | BeFree,GAD,LHGDN | Detail | |
| 0.093 | liver cirrhosis | NA | BeFree,GAD,RGD | Detail | |
| 0.013 | Liver Cirrhosis, Alcoholic | NA | BeFree,GAD | Detail | |
| 0.002 | Biliary cirrhosis | NA | GAD | Detail | |
| 0.120 | Liver Cirrhosis, Experimental | NA | CTD_human | Detail | |
| 0.012 | Liver diseases | NA | BeFree,GAD | Detail | |
| 0.006 | Alcoholic Liver Diseases | NA | BeFree,GAD | Detail | |
| 0.148 | Liver neoplasms | NA | CTD_human,GAD | Detail | |
| 0.001 | Lung diseases | NA | BeFree | Detail | |
| 0.034 | Chronic Obstructive Airway Disease | NA | BeFree,GAD | Detail | |
| 0.212 | Lung Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.016 | Lupus Erythematosus, Systemic | This study aimed to investigate the role of genetic variants of CYP and GST in s... | BeFree,GAD | 24981927 | Detail |
| 0.002 | Lymphatic Metastasis | NA | GAD | Detail | |
| 0.011 | lymphoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Lymphoma, Follicular | NA | BeFree,GAD | Detail | |
| 0.021 | Lymphoma, Non-Hodgkin | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | malaria | Our data suggest a significant role for GSTM1 deletions in complicated Pv (p = 0... | BeFree | 25573779 | Detail |
| 0.003 | Malaria, Falciparum | NA | BeFree,GAD | Detail | |
| 0.037 | Malignant neoplasm of stomach | NA | BeFree,GAD | Detail | |
| 0.007 | Animal Mammary Neoplasms | NA | GAD | Detail | |
| <0.001 | Marijuana Abuse | NA | BeFree | Detail | |
| 0.003 | medulloblastoma | NA | BeFree,GAD | Detail | |
| 0.011 | melanoma | NA | BeFree,GAD | Detail | |
| <0.001 | meningioma | NA | BeFree | Detail | |
| 0.125 | Mesothelioma | NA | CTD_human,GAD,LHGDN | Detail | |
| 0.003 | Metaplasia | NA | LHGDN | Detail | |
| 0.056 | Mouth Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.007 | multiple myeloma | NA | BeFree,GAD | Detail | |
| 0.002 | Multiple Organ Failure | NA | GAD | Detail | |
| 0.007 | multiple sclerosis | NA | GAD,LHGDN | Detail | |
| 0.011 | myocardial infarction | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Nasal Polyps | NA | BeFree | Detail | |
| 0.009 | Nasopharyngeal Neoplasms | NA | GAD | Detail | |
| <0.001 | Nausea | NA | BeFree | Detail | |
| 0.002 | Neoplasm Invasiveness | NA | GAD | Detail | |
| 0.010 | Neoplasm Metastasis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
| 0.002 | Neoplasms, Hormone-Dependent | NA | GAD | Detail | |
| 0.005 | Neoplasms, Multiple Primary | NA | BeFree,GAD | Detail | |
| 0.002 | Neoplasms, Radiation-Induced | NA | GAD | Detail | |
| 0.007 | nephrotic syndrome | NA | GAD,LHGDN | Detail | |
| 0.002 | nervous system disorder | NA | GAD | Detail | |
| 0.003 | neuroblastoma | NA | BeFree,GAD | Detail | |
| <0.001 | acoustic neuroma | NA | BeFree | Detail | |
| 0.003 | neutropenia | NA | BeFree,GAD | Detail | |
| 0.001 | Spots on skin | Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transfera... | BeFree | 14716779 | Detail |
| 0.001 | Exanthema | Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transfera... | BeFree | 14716779 | Detail |
| 0.011 | obesity | NA | BeFree,GAD | Detail | |
| 0.002 | Dermatitis, Occupational | NA | GAD | Detail | |
| 0.005 | Occupational Diseases | NA | BeFree,GAD | Detail | |
| 0.002 | ocular hypertension | NA | GAD | Detail | |
| 0.007 | oligodendroglioma | NA | GAD,LHGDN | Detail | |
| 0.003 | oligospermia | NA | BeFree,GAD | Detail | |
| 0.003 | Disorder of the optic nerve | NA | BeFree,GAD | Detail | |
| <0.001 | optic neuritis | NA | BeFree | Detail | |
| <0.001 | oral submucous fibrosis | NA | BeFree | Detail | |
| 0.005 | Oropharyngeal Neoplasms | NA | GAD | Detail | |
| 0.003 | Degenerative polyarthritis | NA | BeFree,GAD | Detail | |
| 0.003 | osteosarcoma | NA | BeFree,GAD | Detail | |
| 0.004 | ovarian carcinoma | Quantitative assessment of the influence of glutathione S-transferase M1 null va... | BeFree | 25450282 | Detail |
| 0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
| 0.010 | pancreatitis | NA | GAD,LHGDN | Detail | |
| <0.001 | pancytopenia | NA | BeFree | Detail | |
| 0.159 | Parkinson disease | NA | CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Paroxysmal atrial tachycardia | NA | BeFree | Detail | |
| 0.003 | Peptic Ulcer | NA | BeFree,GAD | Detail | |
| 0.011 | periodontitis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | Peripheral neuropathy | NA | GAD | Detail | |
| 0.010 | Pharyngeal Neoplasms | NA | GAD,LHGDN | Detail | |
| <0.001 | Polymorphous light eruption | NA | BeFree | Detail | |
| <0.001 | pituitary adenoma | NA | BeFree | Detail | |
| 0.003 | Pituitary Neoplasms | NA | BeFree,GAD | Detail | |
| 0.002 | Pleural Neoplasms | NA | GAD | Detail | |
| 0.005 | pneumonia | NA | BeFree,GAD | Detail | |
| 0.003 | polycystic ovary syndrome | NA | BeFree,GAD | Detail | |
| <0.001 | polycythemia vera | NA | BeFree | Detail | |
| 0.005 | Adenomatous Polyposis Coli | NA | BeFree,GAD | Detail | |
| 0.005 | Postoperative Complications | NA | GAD | Detail | |
| 0.009 | pre-eclampsia | NA | GAD | Detail | |
| 0.001 | Precancerous Conditions | NA | BeFree | Detail | |
| 0.002 | Pregnancy Complications | NA | GAD | Detail | |
| <0.001 | Preleukemia | NA | BeFree | Detail | |
| 0.021 | Prenatal Exposure Delayed Effects | NA | GAD | Detail | |
| 0.005 | Presbycusis | NA | GAD | Detail | |
| <0.001 | prolactinoma | NA | BeFree | Detail | |
| 0.146 | Prostatic Neoplasms | NA | CTD_human,GAD,LHGDN | Detail | |
| 0.002 | proteinuria | NA | GAD | Detail | |
| 0.002 | Pseudomonas Infections | NA | GAD | Detail | |
| 0.003 | psoriasis | NA | BeFree,GAD | Detail | |
| 0.002 | Psychoses, Substance-Induced | NA | GAD | Detail | |
| 0.006 | pterygium | NA | BeFree,GAD | Detail | |
| <0.001 | pulmonary emphysema | NA | BeFree | Detail | |
| <0.001 | pyruvate carboxylase deficiency disease | NA | BeFree | Detail | |
| 0.123 | Raynaud disease | NA | BeFree,CTD_human,GAD | Detail | |
| 0.003 | Rectal Neoplasms | NA | BeFree,GAD | Detail | |
| <0.001 | kidney failure | NA | BeFree | Detail | |
| 0.082 | Reperfusion Injury | NA | GAD,RGD | Detail | |
| 0.003 | Respiration Disorders | NA | BeFree,GAD | Detail | |
| 0.002 | Respiratory Distress Syndrome, Newborn | NA | GAD | Detail | |
| 0.002 | Respiratory Distress Syndrome, Adult | NA | GAD | Detail | |
| 0.005 | Respiratory Hypersensitivity | NA | GAD | Detail | |
| 0.005 | Respiratory Tract Diseases | NA | BeFree,GAD | Detail | |
| 0.002 | Respiratory Tract Neoplasms | NA | GAD | Detail | |
| 0.002 | Rhinitis, Allergic, Perennial | NA | GAD | Detail | |
| 0.003 | rosacea | NA | BeFree,GAD | Detail | |
| <0.001 | schistosomiasis | NA | BeFree | Detail | |
| 0.011 | schizophrenia | NA | BeFree,GAD | Detail | |
| <0.001 | Residual schizophrenia | NA | BeFree | Detail | |
| <0.001 | systemic scleroderma | NA | BeFree | Detail | |
| <0.001 | Seizures | NA | BeFree | Detail | |
| 0.003 | Age-related cataract | Glutathione S-transferase GSTM 1, null genotype may be associated with susceptib... | BeFree | 25923095 | Detail |
| 0.002 | Septic Shock | NA | GAD | Detail | |
| <0.001 | Signs and Symptoms, Respiratory | NA | BeFree | Detail | |
| 0.129 | Dermatologic disorders | NA | CTD_human,GAD | Detail | |
| <0.001 | Skin Manifestations | NA | BeFree | Detail | |
| 0.007 | Skin Neoplasms | NA | BeFree,GAD | Detail | |
| 0.002 | Stomach Diseases | NA | GAD | Detail | |
| 0.085 | Stomach Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Cerebrovascular accident | NA | BeFree | Detail | |
| 0.002 | Sunburn | NA | GAD | Detail | |
| <0.001 | Temporomandibular Joint Disorders | To investigate the potential role of polymorphisms in matrix metalloproteinase-9... | BeFree | 26244436 | Detail |
| <0.001 | Temporomandibular Joint Dysfunction Syndrome | The C-1562T SNP in the promoter region of the MMP-9 gene, the GSTT1 null, as wel... | BeFree | 26244436 | Detail |
| 0.010 | Testicular Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.027 | Thyroid Neoplasm | NA | GAD,LHGDN | Detail | |
| 0.003 | Thyroid Nodule | NA | BeFree,GAD | Detail | |
| 0.012 | Tobacco use disorder | NA | GAD | Detail | |
| 0.005 | Chromosomal translocation | NA | GAD | Detail | |
| 0.002 | Trisomy | NA | GAD | Detail | |
| 0.016 | tuberculosis | Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced ... | BeFree,GAD | 25525805 | Detail |
| 0.007 | Tuberculosis, Pulmonary | NA | GAD | Detail | |
| 0.002 | Tumor Virus Infections | NA | GAD | Detail | |
| <0.001 | Unipolar Depression | NA | BeFree | Detail | |
| 0.002 | Erythema | NA | GAD | Detail | |
| 0.005 | Urologic Neoplasms | NA | GAD | Detail | |
| 0.120 | urticaria | NA | CTD_human | Detail | |
| <0.001 | Uterine Fibroids | NA | BeFree | Detail | |
| 0.002 | Uterine Neoplasms | NA | GAD | Detail | |
| 0.008 | varicocele | NA | BeFree,GAD | Detail | |
| <0.001 | vasculitis | NA | BeFree | Detail | |
| <0.001 | Virus Diseases | NA | BeFree | Detail | |
| 0.008 | vitiligo | NA | BeFree,GAD | Detail | |
| 0.002 | Wheezing | NA | BeFree | Detail | |
| 0.012 | Helicobacter Infections | NA | GAD | Detail | |
| <0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
| 0.006 | diffuse large B-cell lymphoma | GSTM1 had the highest frequency for gene gain (45.45, 39.18, 31.01, and 34.77%, ... | BeFree,GAD | 25379720 | Detail |
| <0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
| 0.002 | T-Cell Lymphoma | NA | GAD | Detail | |
| 0.005 | motor neuron disease | NA | BeFree,GAD | Detail | |
| 0.002 | Bronchial Hyperreactivity | NA | GAD | Detail | |
| 0.125 | Neoplasms, Second Primary | NA | CTD_human,GAD | Detail | |
| 0.002 | Ovarian Failure, Premature | NA | GAD | Detail | |
| <0.001 | essential hypertension | NA | BeFree | Detail | |
| <0.001 | Encephalopathies | NA | BeFree | Detail | |
| 0.002 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | Chronic gastritis | NA | BeFree | Detail | |
| 0.002 | Alcohol abuse | NA | GAD | Detail | |
| <0.001 | Xeroderma Pigmentosum, Complementation Group D | We assessed polymorphisms in the aryl hydrocarbon receptor (AhR-Arg554Lys), null... | BeFree | 15459223 | Detail |
| 0.019 | cataract | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Pancreatitis, Chronic | Glutathione S-transferase M1 and glutathione S-transferase T1 genotype in chroni... | BeFree,GAD | 25378345 | Detail |
| 0.003 | Squamous cell carcinoma of lung | GSTM1 had the highest frequency for gene gain (45.45, 39.18, 31.01, and 34.77%, ... | BeFree | 25379720 | Detail |
| 0.005 | Small cell carcinoma of lung | Subgroup analysis showed a significant relationship between squamous carcinoma (... | BeFree,GAD | 25036724 | Detail |
| 0.003 | Migraine Disorders | NA | BeFree,GAD | Detail | |
| 0.009 | Premature Birth | NA | GAD | Detail | |
| 0.001 | Oral Cavity Carcinoma | NA | BeFree | Detail | |
| <0.001 | Cutaneous Melanoma | NA | BeFree | Detail | |
| 0.004 | Adenocarcinoma of lung (disorder) | NA | BeFree,GAD | Detail | |
| 0.008 | esophageal carcinoma | In this study, we assessed the association of functional polymorphisms in GSTM1 ... | BeFree,GAD | 25432134 | Detail |
| <0.001 | congenital heart disease | NA | BeFree | Detail | |
| 0.003 | lingual-facial-buccal dyskinesia | NA | BeFree,GAD | Detail | |
| 0.002 | low tension glaucoma | NA | GAD | Detail | |
| 0.016 | Malignant neoplasm of mouth | The results also suggested significant association between tobacco habits, espec... | BeFree,GAD | 23444898 | Detail |
| 0.016 | Malignant neoplasm of mouth | Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along wi... | BeFree,GAD | 25735346 | Detail |
| 0.016 | Malignant neoplasm of mouth | Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A... | BeFree,GAD | 26166128 | Detail |
| <0.001 | Malignant neoplasm of oropharynx | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of nasopharynx | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pharynx | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of anus | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of gallbladder | NA | BeFree,GAD | Detail | |
| <0.001 | acute myocardial infarction | NA | BeFree | Detail | |
| <0.001 | allergic asthma | These novel data provide a potential mechanism of the genomic link between GSTM1... | BeFree | 25118837 | Detail |
| <0.001 | adrenoleukodystrophy | NA | BeFree | Detail | |
| <0.001 | porphyria cutanea tarda | NA | BeFree | Detail | |
| 0.003 | HELLP syndrome | NA | BeFree,GAD | Detail | |
| 0.002 | Dermatitis, Allergic Contact | NA | GAD | Detail | |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | Dysplastic Nevus | NA | BeFree | Detail | |
| 0.005 | exfoliation syndrome | NA | BeFree,GAD | Detail | |
| 0.002 | germinoma | NA | GAD | Detail | |
| 0.002 | Papillary and follicular adenocarcinoma | NA | GAD | Detail | |
| 0.003 | Carcinoma, Large Cell | NA | BeFree,GAD | Detail | |
| 0.011 | Cervical Intraepithelial Neoplasia | NA | BeFree,GAD | Detail | |
| 0.007 | Squamous Cell Neoplasms | NA | GAD,LHGDN | Detail | |
| <0.001 | childhood brain tumor | NA | BeFree | Detail | |
| <0.001 | childhood non-Hodgkin's lymphoma | NA | BeFree | Detail | |
| <0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
| <0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
| 0.008 | Lip and oral cavity carcinoma | The results also suggested significant association between tobacco habits, espec... | BeFree | 23444898 | Detail |
| 0.008 | Lip and oral cavity carcinoma | Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along wi... | BeFree | 25735346 | Detail |
| 0.008 | Lip and oral cavity carcinoma | Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A... | BeFree | 26166128 | Detail |
| <0.001 | Memory impairment | NA | BeFree | Detail | |
| 0.002 | Neurotoxicity Syndromes | NA | GAD | Detail | |
| 0.002 | Respiratory Depression | NA | GAD | Detail | |
| 0.002 | Ototoxicity | NA | GAD | Detail | |
| 0.001 | gallbladder carcinoma | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| 0.002 | Alcohol-Related Disorders | NA | GAD | Detail | |
| 0.125 | Amphetamine-Related Disorders | NA | CTD_human,GAD | Detail | |
| 0.002 | Substance-Related Disorders | NA | GAD | Detail | |
| <0.001 | Alcohol-Induced Disorders | NA | BeFree | Detail | |
| 0.006 | Cancer of Nasopharynx | NA | BeFree,GAD | Detail | |
| <0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
| 0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
| 0.003 | Hepatitis, Autoimmune | NA | BeFree,GAD | Detail | |
| 0.002 | Dyslipidemias | NA | GAD | Detail | |
| 0.126 | Malignant neoplasm of lung | The absence of GSTM1 and GSTT1 genes increases the risk of lung cancer because o... | BeFree,GAD | 24852519 | Detail |
| 0.126 | Malignant neoplasm of lung | Copy number polymorphism of glutathione-S-transferase genes (GSTM1 & GSTT1) in s... | BeFree,GAD | 25027082 | Detail |
| 0.126 | Malignant neoplasm of lung | Meta-analysis of GSTM1 null genotype and lung cancer risk in Asians. | BeFree,GAD | 25033877 | Detail |
| 0.126 | Malignant neoplasm of lung | An increased risk of lung cancer with GSTM1 and GSTT1 null genotype, especially ... | BeFree,GAD | 25036724 | Detail |
| 0.126 | Malignant neoplasm of lung | The smokers with CYP1A1 Msp1 (wt/vt+vt/vt), CYP1A1 exon7 (Val/Val+Ile /Val), GST... | BeFree,GAD | 25040976 | Detail |
| 0.126 | Malignant neoplasm of lung | GSTM1 polymorphisms and lung cancer risk in the Chinese population: a meta-analy... | BeFree,GAD | 25292056 | Detail |
| 0.126 | Malignant neoplasm of lung | The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, ... | BeFree,GAD | 25388590 | Detail |
| 0.126 | Malignant neoplasm of lung | Our results suggest that oxidative damage may be play a important role in patien... | BeFree,GAD | 25472599 | Detail |
| 0.126 | Malignant neoplasm of lung | The association of GSTM1 deletion polymorphism with lung cancer risk in Chinese ... | BeFree,GAD | 25797617 | Detail |
| 0.006 | age related macular degeneration | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Acute Lung Injury | NA | GAD | Detail | |
| 0.005 | Oxidative Stress | NA | GAD | Detail | |
| 0.002 | Mucosa-Associated Lymphoid Tissue Lymphoma | NA | GAD | Detail | |
| 0.002 | multiple chemical sensitivity | NA | GAD | Detail | |
| 0.002 | Sepsis | NA | GAD | Detail | |
| 0.002 | Hearing problem | NA | GAD | Detail | |
| 0.007 | Carcinoma, Small Cell | NA | BeFree,GAD,LHGDN | Detail | |
| 0.120 | Chloracne | NA | BeFree,CTD_human | Detail | |
| <0.001 | Chronic arthritis | NA | BeFree | Detail | |
| 0.005 | Childhood asthma | Gender-dependent effect of GSTM1 genotype on childhood asthma associated with pr... | BeFree,GAD | 25328891 | Detail |
| <0.001 | Miller Dieker syndrome | NA | BeFree | Detail | |
| <0.001 | Xeroderma Pigmentosum, Complementation Group D | NA | BeFree | Detail | |
| <0.001 | 5,10-Methylenetetrahydrofolate reductase deficiency | NA | BeFree | Detail | |
| <0.001 | Cortical cataract | NA | BeFree | Detail | |
| <0.001 | Impaired glucose tolerance | NA | BeFree | Detail | |
| <0.001 | Acquired aplastic anemia | NA | BeFree | Detail | |
| <0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
| 0.032 | Cancer of Head and Neck | Risk modulation of GSTM1–GSTT1 interactions to head and neck cancer in tobacco u... | BeFree,GAD | 25015263 | Detail |
| 0.032 | Cancer of Head and Neck | Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and... | BeFree,GAD | 25724184 | Detail |
| 0.002 | Squamous cell carcinoma of esophagus | Association between GSTM1 and GSTT1 polymorphisms and esophageal squamous cell c... | BeFree | 25432134 | Detail |
| <0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
| <0.001 | anal carcinoma | NA | BeFree | Detail | |
| <0.001 | cervical squamous cell carcinoma | The association of GSTM1 and GSTT1 polymorphisms with squamous cell carcinoma of... | BeFree | 25663492 | Detail |
| <0.001 | cervical squamous cell carcinoma | The results suggest that the GSTM1 deletion polymorphism is not a risk factor fo... | BeFree | 25773790 | Detail |
| <0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | bladder squamous cell carcinoma | NA | BeFree | Detail | |
| <0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | Acute Undifferentiated Leukemia | NA | BeFree | Detail | |
| <0.001 | stage, ovarian epithelial cancer | NA | BeFree | Detail | |
| <0.001 | laryngeal squamous cell carcinoma | NA | BeFree | Detail | |
| <0.001 | secondary acute myeloid leukemia | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
| 0.005 | Iron Overload | NA | GAD,LHGDN | Detail | |
| 0.014 | cervix carcinoma | This study aims to investigate the clinical impact of glutathione-S-transferase ... | BeFree,GAD | 25663492 | Detail |
| 0.014 | cervix carcinoma | Lack of participation of the GSTM1 polymorphism in cervical cancer development i... | BeFree,GAD | 25773790 | Detail |
| 0.005 | Arsenic Poisoning | NA | GAD | Detail | |
| 0.002 | Atrophic | NA | GAD | Detail | |
| <0.001 | Non-arteritic ischemic optic neuropathy | NA | BeFree | Detail | |
| 0.003 | Glaucoma, Primary Open Angle | The combined GSTM1 null and GSTT1-present genotypes were more frequent in the pr... | BeFree | 25366778 | Detail |
| <0.001 | Chronic liver disease | NA | BeFree | Detail | |
| <0.001 | endometriosis of uterus | NA | BeFree | Detail | |
| <0.001 | Human papilloma virus infection | NA | BeFree | Detail | |
| <0.001 | Absence of pain sensation | NA | BeFree | Detail | |
| 0.012 | Malignant neoplasm of liver | NA | BeFree,GAD | Detail | |
| 0.003 | malignant mesothelioma | NA | BeFree,GAD | Detail | |
| 0.006 | Malignant neoplasm of pancreas | NA | BeFree,GAD | Detail | |
| <0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of vulva | NA | BeFree | Detail | |
| 0.092 | Malignant neoplasm of prostate | Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Ca... | BeFree,GAD | 25198353 | Detail |
| 0.092 | Malignant neoplasm of prostate | Systematic analysis on the GSTM1 null phenotype and prostate cancer risk in Chin... | BeFree,GAD | 25773803 | Detail |
| 0.002 | Hematologic Neoplasms | NA | GAD | Detail | |
| 0.005 | Chromosome Breakage | NA | GAD | Detail | |
| 0.005 | Pancreatitis, Alcoholic | NA | BeFree,GAD | Detail | |
| 0.121 | Non-alcoholic Fatty Liver Disease | NA | BeFree,CTD_human | Detail | |
| 0.003 | Chronic Kidney Insufficiency | NA | BeFree,GAD | Detail | |
| <0.001 | Noise-induced temporary threshold shift | NA | BeFree | Detail | |
| 0.003 | neuropathy | NA | BeFree,GAD | Detail | |
| 0.002 | Toxic effect of formaldehyde | NA | GAD | Detail | |
| 0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| <0.001 | Bilateral cataracts (disorder) | NA | BeFree | Detail | |
| <0.001 | Metabolic syndrome X | NA | BeFree | Detail | |
| 0.120 | Neurodegenerative Disorders | NA | BeFree,CTD_human | Detail | |
| 0.005 | Hepatitis B, Chronic | NA | BeFree,GAD | Detail | |
| 0.005 | Hepatitis C, Chronic | NA | GAD | Detail | |
| <0.001 | Mood Disorders | Logistic regression analyses showed that comorbid mood disorders and TUD were as... | BeFree | 25445355 | Detail |
| <0.001 | Environmental Carcinogenesis | NA | BeFree | Detail | |
| 0.045 | Malignant neoplasm of esophagus | In this study, we assessed the association of functional polymorphisms in GSTM1 ... | BeFree,GAD | 25432134 | Detail |
| 0.004 | Thyroid carcinoma | NA | BeFree,GAD | Detail | |
| 0.002 | Methotrexate poisoning | NA | GAD | Detail | |
| <0.001 | Carotid Atherosclerosis | NA | BeFree | Detail | |
| <0.001 | Cutaneous hypersensitivity | NA | BeFree | Detail | |
| <0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
| 0.003 | Carcinoma of larynx | NA | BeFree | Detail | |
| 0.008 | Carcinogenesis | NA | BeFree | Detail | |
| <0.001 | Leukemogenesis | NA | BeFree | Detail | |
| 0.012 | prostate carcinoma | Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Ca... | BeFree | 25198353 | Detail |
| 0.012 | prostate carcinoma | Systematic analysis on the GSTM1 null phenotype and prostate cancer risk in Chin... | BeFree | 25773803 | Detail |
| 0.002 | Manganese Poisoning | NA | GAD | Detail | |
| <0.001 | CARCINOMA OF VULVA | NA | BeFree | Detail | |
| <0.001 | Gastro-esophageal reflux disease with esophagitis | NA | BeFree | Detail | |
| 0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| <0.001 | invasive cancer | NA | BeFree | Detail | |
| 0.022 | breast carcinoma | NA | BeFree | Detail | |
| 0.047 | Carcinoma of lung | The absence of GSTM1 and GSTT1 genes increases the risk of lung cancer because o... | BeFree | 24852519 | Detail |
| 0.047 | Carcinoma of lung | Copy number polymorphism of glutathione-S-transferase genes (GSTM1 & GSTT1) in s... | BeFree | 25027082 | Detail |
| 0.047 | Carcinoma of lung | Meta-analysis of GSTM1 null genotype and lung cancer risk in Asians. | BeFree | 25033877 | Detail |
| 0.047 | Carcinoma of lung | An increased risk of lung cancer with GSTM1 and GSTT1 null genotype, especially ... | BeFree | 25036724 | Detail |
| 0.047 | Carcinoma of lung | The smokers with CYP1A1 Msp1 (wt/vt+vt/vt), CYP1A1 exon7 (Val/Val+Ile /Val), GST... | BeFree | 25040976 | Detail |
| 0.047 | Carcinoma of lung | GSTM1 polymorphisms and lung cancer risk in the Chinese population: a meta-analy... | BeFree | 25292056 | Detail |
| 0.047 | Carcinoma of lung | The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, ... | BeFree | 25388590 | Detail |
| 0.047 | Carcinoma of lung | Our results suggest that oxidative damage may be play a important role in patien... | BeFree | 25472599 | Detail |
| 0.047 | Carcinoma of lung | The association of GSTM1 deletion polymorphism with lung cancer risk in Chinese ... | BeFree | 25797617 | Detail |
| <0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
| 0.002 | Tardive Dyskinesia | NA | GAD | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| <0.001 | Cancer Relapse | NA | BeFree | Detail | |
| 0.006 | colon carcinoma | NA | BeFree | Detail | |
| 0.014 | stomach carcinoma | NA | BeFree | Detail | |
| 0.008 | skin carcinoma | NA | BeFree,GAD | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| 0.002 | Organophosphate poisoning | NA | GAD | Detail | |
| <0.001 | Severe chronic obstructive pulmonary disease | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of kidney | NA | BeFree,GAD | Detail | |
| <0.001 | cervical cancer squamous cell | NA | BeFree | Detail | |
| <0.001 | Chronic lung disease | NA | BeFree | Detail | |
| <0.001 | early pregnancy | NA | BeFree | Detail | |
| 0.002 | Mitochondrial Diseases | NA | GAD | Detail | |
| <0.001 | Cleft lip with or without cleft palate | NA | BeFree | Detail | |
| <0.001 | malignant pleural mesothelioma | NA | BeFree | Detail | |
| <0.001 | psychological distress | NA | BeFree | Detail | |
| 0.001 | Spots on skin | NA | BeFree | Detail | |
| 0.003 | hypospadias | NA | BeFree,GAD | Detail | |
| 0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
| <0.001 | Smoker's lung | NA | BeFree | Detail | |
| 0.148 | Drug-Induced Liver Injury | NA | CTD_human,GAD | Detail | |
| 0.002 | Cardiomyopathies | NA | GAD | Detail | |
| 0.102 | Malignant neoplasm of breast | Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 p... | BeFree | 17180579 | Detail |
| 0.010 | ovarian neoplasm | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Genomic Instability | NA | GAD | Detail | |
| 0.005 | Microsatellite Instability | NA | GAD | Detail | |
| <0.001 | Environment-Related Malignant Neoplasm | NA | BeFree | Detail | |
| <0.001 | precancerous lesions | This suggests that GSTM1 null genotype in cervical cell samples may be associate... | BeFree | 25663492 | Detail |
| 0.003 | Colorectal cancer metastatic | NA | BeFree,GAD | Detail | |
| <0.001 | Venoocclusive disease | NA | BeFree | Detail | |
| 0.012 | Papillomavirus Infections | NA | GAD | Detail | |
| 0.028 | Malignant neoplasm of ovary | Quantitative assessment of the influence of glutathione S-transferase M1 null va... | BeFree,GAD | 25450282 | Detail |
| 0.009 | Squamous cell carcinoma of the head and neck | In MDR analysis, the best model for HNSCC risk was the four-factor model of toba... | BeFree,GAD | 25724184 | Detail |
| 0.022 | breast carcinoma | Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 p... | BeFree | 17180579 | Detail |
| 0.002 | sarcoma | NA | GAD | Detail | |
| 0.002 | Mesothelioma (malignant, clinical disorder) (disorder) | NA | GAD | Detail | |
| <0.001 | Deficiency of transferase | NA | BeFree | Detail | |
| 0.002 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| 0.003 | Adenoma of large intestine | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of large intestine | NA | BeFree | Detail | |
| <0.001 | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | NA | BeFree | Detail | |
| <0.001 | Cervical Squamous Intraepithelial Neoplasia | NA | BeFree | Detail | |
| <0.001 | childhood leukemia | NA | BeFree | Detail | |
| <0.001 | Esophageal Squamous Intraepithelial Neoplasia | NA | BeFree | Detail | |
| <0.001 | gastric cardia carcinoma | NA | BeFree | Detail | |
| <0.001 | Hereditary Nonpolyposis Colorectal Cancer | NA | BeFree | Detail | |
| 0.001 | Sporadic Breast Carcinoma | NA | BeFree | Detail | |
| <0.001 | Testicular Germ Cell Tumor | NA | BeFree | Detail | |
| <0.001 | Treatment related acute myeloid leukaemia | NA | BeFree | Detail | |
| <0.001 | Undifferentiated leukemia | NA | BeFree | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| 0.012 | hearing impairment | NA | GAD | Detail | |
| 0.120 | Micronuclei, Chromosome-Defective | NA | CTD_human | Detail | |
| 0.045 | Mammary Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.002 | oxyphilic adenoma | NA | GAD | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| 0.094 | colorectal cancer | Analysis for ethnicity and smoking for each of the investigated polymorphisms sh... | BeFree,GAD | 25249451 | Detail |
| 0.094 | colorectal cancer | In conclusion, the GSTT1 and GSTM1 polymorphisms, but not GSTP1, may modulate th... | BeFree,GAD | 25408579 | Detail |
| 0.094 | colorectal cancer | Association between glutathione S-transferase M1 and T1 polymorphisms and colore... | BeFree,GAD | 25807650 | Detail |
| 0.002 | Sjogren's syndrome | NA | GAD | Detail | |
| <0.001 | Rectal Tumors | NA | BeFree | Detail | |
| <0.001 | Chronic Kidney Diseases | NA | BeFree | Detail | |
| 0.003 | Cirrhosis | NA | BeFree,GAD | Detail | |
| <0.001 | Penile hypospadias | NA | BeFree | Detail | |
| 0.002 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| <0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
| <0.001 | Meningioma, benign, no ICD-O subtype | NA | BeFree | Detail | |
| 0.003 | Slow acetylator due to N-acetyltransferase enzyme variant | Interactive analysis showed that NAT2 slow acetylator and the GSTM1 null genotyp... | BeFree | 25501156 | Detail |
| 0.002 | Fast acetylator due to N-acetyltransferase enzyme variant | NA | BeFree | Detail | |
| <0.001 | TIBIAL MUSCULAR DYSTROPHY, TARDIVE | The C-1562T SNP in the promoter region of the MMP-9 gene, the GSTT1 null, as wel... | BeFree | 26244436 | Detail |
| 0.003 | Mammographic Density | NA | BeFree,GAD | Detail | |
| 0.001 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | NA | BeFree | Detail | |
| 0.002 | MUTAGEN SENSITIVITY | NA | GAD | Detail | |
| <0.001 | PHOTOPAROXYSMAL RESPONSE 1 | NA | BeFree | Detail | |
| 0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.041 | coronary artery disease | Association between GSTM1 null genotype and coronary artery disease risk: a meta... | BeFree,GAD,LHGDN | 25183432 | Detail |
| <0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
| 0.054 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD | Detail | |
| 0.002 | Proteinuria Adverse Event | NA | GAD | Detail | |
| <0.001 | Urothelial Carcinoma | NA | BeFree | Detail | |
| 0.169 | liver carcinoma | Glutathione S-transferase M1 null genotype and hepatocellular carcinoma suscepti... | BeFree,CTD_human,GAD,LHGDN | 24998552 | Detail |
| 0.169 | liver carcinoma | GSTM1 had the highest frequency for gene gain (45.45, 39.18, 31.01, and 34.77%, ... | BeFree,CTD_human,GAD,LHGDN | 25379720 | Detail |
| <0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
| <0.001 | Oropharyngeal Carcinoma | NA | BeFree | Detail | |
| 0.002 | Airway Remodeling | NA | GAD | Detail | |
| 0.002 | Drug-Induced Liver Injury, Chronic | NA | GAD | Detail | |
| 0.003 | Chronic ulcerative colitis | NA | BeFree,GAD | Detail | |
| 0.005 | Nasopharyngeal carcinoma | NA | BeFree,GAD | Detail | |
| 0.007 | Prostatic Hyperplasia | NA | GAD | Detail | |
| 0.002 | Solar Erythema | NA | GAD | Detail | |
| <0.001 | Persistent asthma | NA | BeFree | Detail | |
| 0.015 | myelodysplastic syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | Juvenile arthritis | NA | BeFree,GAD | Detail | |
| <0.001 | Allergic disposition | In analyzing GSTM1, GSTT1, and GSTP1 sequence variation, we observed other commo... | BeFree | 25515186 | Detail |
| <0.001 | Neutrophilia (disorder) | These novel data provide a potential mechanism of the genomic link between GSTM1... | BeFree | 25118837 | Detail |
| 0.002 | Infection | NA | GAD | Detail | |
| <0.001 | juvenile rheumatoid arthritis | NA | BeFree | Detail | |
| 0.004 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | Pneumonia in children | NA | BeFree | Detail | |
| 0.002 | Mountain Sickness | NA | GAD | Detail | |
| 0.012 | Hearing Loss | NA | GAD | Detail | |
| 0.002 | Oral cleft | NA | GAD | Detail | |
| 0.094 | colorectal cancer | The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.8... | BeFree | 20937634 | Detail |
| 0.014 | colorectal carcinoma | The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.8... | BeFree | 20937634 | Detail |
| <0.001 | Abdominal Neoplasms | NA | BeFree | Detail | |
| 0.003 | Congenital Abnormality | NA | BeFree,GAD | Detail | |
| 0.002 | Spontaneous abortion | NA | GAD | Detail | |
| 0.002 | Abortion, Habitual | NA | GAD | Detail | |
| <0.001 | acute pancreatitis | NA | BeFree | Detail | |
| 0.053 | adenocarcinoma | Subgroup analysis showed a significant relationship between squamous carcinoma (... | BeFree,GAD,LHGDN | 25036724 | Detail |
| 0.017 | adenoma | NA | BeFree,GAD | Detail | |
| <0.001 | AIDS related complex | This data may provide evidence that GSTM 1 gene polymorphisms may be associated ... | BeFree | 25923095 | Detail |
| 0.012 | Alcoholic Intoxication, Chronic | NA | BeFree,GAD | Detail | |
| 0.002 | Altitude Sickness | NA | GAD | Detail | |
| 0.005 | Alzheimer's disease | NA | GAD | Detail | |
| 0.003 | anemia | NA | BeFree,GAD | Detail | |
| 0.008 | aplastic anemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Aneuploidy | NA | GAD | Detail | |
| <0.001 | Anxiety Disorders | NA | BeFree | Detail | |
| 0.002 | arteriosclerosis | NA | BeFree | Detail | |
| 0.002 | arthritis | NA | GAD | Detail | |
| 0.020 | rheumatoid arthritis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | asbestosis | NA | BeFree,GAD | Detail | |
| 0.002 | Ascorbic Acid Deficiency | NA | GAD | Detail | |
| 0.002 | asphyxia neonatorum | NA | GAD | Detail | |
| 0.232 | asthma | Glutathione S-transferase M1 modulates allergen-induced NF-κB activation in asth... | BeFree,CTD_human,GAD,LHGDN | 25118837 | Detail |
| 0.232 | asthma | This study demonstrates that the GSTM1 null genotype presents a protective effec... | BeFree,CTD_human,GAD,LHGDN | 25328891 | Detail |
| 0.009 | Astrocytoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.141 | atherosclerosis | NA | BeFree,CTD_human,GAD | Detail | |
| 0.126 | autistic disorder | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | azoospermia | NA | BeFree | Detail | |
| 0.005 | Balkan nephropathy | NA | BeFree,GAD | Detail | |
| 0.010 | Barrett esophagus | NA | BeFree,GAD | Detail | |
| <0.001 | Basal Cell Nevus Syndrome | NA | BeFree | Detail | |
| 0.154 | Bladder Neoplasm | Patients with urinary bladder neoplasms who had been followed up for a 5-year pe... | BeFree | 17469025 | Detail |
| 0.008 | Behcet Syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| 0.005 | beta thalassemia | NA | GAD | Detail | |
| <0.001 | bipolar disorder | NA | BeFree | Detail | |
| 0.154 | Bladder Neoplasm | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Blast Phase | NA | BeFree | Detail | |
| 0.002 | Bone Marrow Diseases | NA | GAD | Detail | |
| <0.001 | borderline personality disorder | NA | BeFree | Detail | |
| 0.021 | Brain Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.102 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
| 0.002 | bronchitis | NA | GAD | Detail | |
| <0.001 | bronchopulmonary dysplasia | NA | BeFree | Detail | |
| <0.001 | Burkitt lymphoma | NA | BeFree | Detail | |
| 0.006 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| 0.006 | Malignant neoplasm of larynx | NA | BeFree,GAD | Detail | |
| 0.001 | Rectal Carcinoma | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| 0.002 | basal cell carcinoma | NA | GAD | Detail | |
| <0.001 | Bronchogenic Carcinoma | NA | BeFree | Detail | |
| 0.005 | Non-small cell lung carcinoma | Genetic polymorphisms of glutathione S-transferase M1 and T1, and evaluation of ... | BeFree,GAD | 25472599 | Detail |
| 0.007 | Carcinoma, Papillary | NA | GAD | Detail | |
| 0.133 | renal cell carcinoma | NA | BeFree,CTD_human,GAD | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| Subgroup analysis showed a significant relationship between squamous carcinoma (SC), adenocarcinoma ... | DisGeNET | Detail |
| GSTM1 exhibited a significant association with increased risk of squamous cell carcinoma (p < 0.001)... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study aims to investigate the clinical impact of glutathione-S-transferase GSTM1 and GSTT1 poly... | DisGeNET | Detail |
| Lack of participation of the GSTM1 polymorphism in cervical cancer development in Northeast Thailand... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Conversely, the expression levels of liver detoxification enzymes, UGT2B4/7, SULT2A1, GSTA1-4, and G... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study was conducted to determine the association between arsenic exposure and polymorphisms of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Analysis for ethnicity and smoking for each of the investigated polymorphisms showed that some genot... | DisGeNET | Detail |
| In conclusion, the GSTT1 and GSTM1 polymorphisms, but not GSTP1, may modulate the CRC risk among Chi... | DisGeNET | Detail |
| Association between glutathione S-transferase M1 and T1 polymorphisms and colorectal cancer risk in ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between GSTM1 null genotype and coronary artery disease risk: a meta-analysis. | DisGeNET | Detail |
| Association between GSTM1 null genotype and coronary artery disease risk: a meta-analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Null genotypes of GSTM1 and GSTT1 and endometriosis risk: a meta-analysis of 25 case-control studies... | DisGeNET | Detail |
| Glutathione S-transferase M1 polymorphism and endometriosis susceptibility: a meta-analysis. | DisGeNET | Detail |
| Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) and endometriosis risk: a meta-... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Effects of glutathione S-transferase M1 and T1 deletions on epilepsy risk among a Tunisian populatio... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In this study, we assessed the association of functional polymorphisms in GSTM1 and GSTT1 with esoph... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The GSTM1 null genotype was more frequent in the glaucoma group than in the control group (P = 0.000... | DisGeNET | Detail |
| Is the GSTM1 null polymorphism a risk factor for primary angle-closure glaucoma among Iranian popula... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) null polymorphisms and the risk of hypertension:... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glutathione S-transferase Mu-1 gene polymorphism in Egyptian patients with idiopathic male infertili... | DisGeNET | Detail |
| Our findings also underrate the significance of the effect of GSTM1 and/or GSTT1 (especially the for... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Meta-analysis included 22, 10 and 20 studies examining the association of childhood ALL with GSTM1, ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Based on these findings, we find that the interaction between GSTT1 and GSTM1 seems to influence tre... | DisGeNET | Detail |
| Role of glutathione-S-transferase M1 (GSTM1) and T1 (GSTT1) genes in the development and progress of... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study aimed to investigate the role of genetic variants of CYP and GST in susceptibility and cl... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our data suggest a significant role for GSTM1 deletions in complicated Pv (p = 0.0007) malaria with ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transferase theta1 (GSTT1), m... | DisGeNET | Detail |
| Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transferase theta1 (GSTT1), m... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Quantitative assessment of the influence of glutathione S-transferase M1 null variant on ovarian can... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glutathione S-transferase GSTM 1, null genotype may be associated with susceptibility to age-related... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To investigate the potential role of polymorphisms in matrix metalloproteinase-9 (MMP-9), glutathion... | DisGeNET | Detail |
| The C-1562T SNP in the promoter region of the MMP-9 gene, the GSTT1 null, as well as the combined GS... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Ch... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| GSTM1 had the highest frequency for gene gain (45.45, 39.18, 31.01, and 34.77%, respectively) and fo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We assessed polymorphisms in the aryl hydrocarbon receptor (AhR-Arg554Lys), null variants of the glu... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glutathione S-transferase M1 and glutathione S-transferase T1 genotype in chronic pancreatitis: a me... | DisGeNET | Detail |
| GSTM1 had the highest frequency for gene gain (45.45, 39.18, 31.01, and 34.77%, respectively) and fo... | DisGeNET | Detail |
| Subgroup analysis showed a significant relationship between squamous carcinoma (SC), adenocarcinoma ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In this study, we assessed the association of functional polymorphisms in GSTM1 and GSTT1 with esoph... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The results also suggested significant association between tobacco habits, especially chewing, varia... | DisGeNET | Detail |
| Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along with variant alleles o... | DisGeNET | Detail |
| Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These novel data provide a potential mechanism of the genomic link between GSTM1 polymorphism and ai... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The results also suggested significant association between tobacco habits, especially chewing, varia... | DisGeNET | Detail |
| Our findings suggest that presence of GSTM1 and/or GSTT1 null genotypes along with variant alleles o... | DisGeNET | Detail |
| Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The absence of GSTM1 and GSTT1 genes increases the risk of lung cancer because of radon exposure. | DisGeNET | Detail |
| Copy number polymorphism of glutathione-S-transferase genes (GSTM1 & GSTT1) in susceptibility to lun... | DisGeNET | Detail |
| Meta-analysis of GSTM1 null genotype and lung cancer risk in Asians. | DisGeNET | Detail |
| An increased risk of lung cancer with GSTM1 and GSTT1 null genotype, especially with dual null genot... | DisGeNET | Detail |
| The smokers with CYP1A1 Msp1 (wt/vt+vt/vt), CYP1A1 exon7 (Val/Val+Ile /Val), GSTM1 (-), GSTM3 (AB+BB... | DisGeNET | Detail |
| GSTM1 polymorphisms and lung cancer risk in the Chinese population: a meta-analysis based on 47 stud... | DisGeNET | Detail |
| The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, CYP2D6*4, GSTP1, GST... | DisGeNET | Detail |
| Our results suggest that oxidative damage may be play a important role in patients with N-SCLC, and ... | DisGeNET | Detail |
| The association of GSTM1 deletion polymorphism with lung cancer risk in Chinese population: evidence... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Gender-dependent effect of GSTM1 genotype on childhood asthma associated with prenatal tobacco smoke... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Risk modulation of GSTM1–GSTT1 interactions to head and neck cancer in tobacco users. | DisGeNET | Detail |
| Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction w... | DisGeNET | Detail |
| Association between GSTM1 and GSTT1 polymorphisms and esophageal squamous cell carcinoma: results fr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The association of GSTM1 and GSTT1 polymorphisms with squamous cell carcinoma of cervix in Pakistan. | DisGeNET | Detail |
| The results suggest that the GSTM1 deletion polymorphism is not a risk factor for squamous cell carc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study aims to investigate the clinical impact of glutathione-S-transferase GSTM1 and GSTT1 poly... | DisGeNET | Detail |
| Lack of participation of the GSTM1 polymorphism in cervical cancer development in Northeast Thailand... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The combined GSTM1 null and GSTT1-present genotypes were more frequent in the primary open-angle gla... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Caribbean population o... | DisGeNET | Detail |
| Systematic analysis on the GSTM1 null phenotype and prostate cancer risk in Chinese people. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Logistic regression analyses showed that comorbid mood disorders and TUD were associated with signif... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In this study, we assessed the association of functional polymorphisms in GSTM1 and GSTT1 with esoph... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Copy number variation of GSTT1 and GSTM1 and the risk of prostate cancer in a Caribbean population o... | DisGeNET | Detail |
| Systematic analysis on the GSTM1 null phenotype and prostate cancer risk in Chinese people. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The absence of GSTM1 and GSTT1 genes increases the risk of lung cancer because of radon exposure. | DisGeNET | Detail |
| Copy number polymorphism of glutathione-S-transferase genes (GSTM1 & GSTT1) in susceptibility to lun... | DisGeNET | Detail |
| Meta-analysis of GSTM1 null genotype and lung cancer risk in Asians. | DisGeNET | Detail |
| An increased risk of lung cancer with GSTM1 and GSTT1 null genotype, especially with dual null genot... | DisGeNET | Detail |
| The smokers with CYP1A1 Msp1 (wt/vt+vt/vt), CYP1A1 exon7 (Val/Val+Ile /Val), GSTM1 (-), GSTM3 (AB+BB... | DisGeNET | Detail |
| GSTM1 polymorphisms and lung cancer risk in the Chinese population: a meta-analysis based on 47 stud... | DisGeNET | Detail |
| The aim of this study was to evaluate the contribution of CYP1A1*2A, CYP1A1*2C, CYP2D6*4, GSTP1, GST... | DisGeNET | Detail |
| Our results suggest that oxidative damage may be play a important role in patients with N-SCLC, and ... | DisGeNET | Detail |
| The association of GSTM1 deletion polymorphism with lung cancer risk in Chinese population: evidence... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 positive/null, GSTM1 ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This suggests that GSTM1 null genotype in cervical cell samples may be associated with more severe p... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Quantitative assessment of the influence of glutathione S-transferase M1 null variant on ovarian can... | DisGeNET | Detail |
| In MDR analysis, the best model for HNSCC risk was the four-factor model of tobacco-betel quid chewi... | DisGeNET | Detail |
| Genetic polymorphisms of glutathione S-transferase (GST) genes including GSTT1 positive/null, GSTM1 ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Analysis for ethnicity and smoking for each of the investigated polymorphisms showed that some genot... | DisGeNET | Detail |
| In conclusion, the GSTT1 and GSTM1 polymorphisms, but not GSTP1, may modulate the CRC risk among Chi... | DisGeNET | Detail |
| Association between glutathione S-transferase M1 and T1 polymorphisms and colorectal cancer risk in ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interactive analysis showed that NAT2 slow acetylator and the GSTM1 null genotype were mutually syne... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The C-1562T SNP in the promoter region of the MMP-9 gene, the GSTT1 null, as well as the combined GS... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between GSTM1 null genotype and coronary artery disease risk: a meta-analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glutathione S-transferase M1 null genotype and hepatocellular carcinoma susceptibility in China and ... | DisGeNET | Detail |
| GSTM1 had the highest frequency for gene gain (45.45, 39.18, 31.01, and 34.77%, respectively) and fo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In analyzing GSTM1, GSTT1, and GSTP1 sequence variation, we observed other common functional variant... | DisGeNET | Detail |
| These novel data provide a potential mechanism of the genomic link between GSTM1 polymorphism and ai... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.9... | DisGeNET | Detail |
| The CYP1A1-3801-CC (AOR = 0.47, 95% CI: 0.23, 0.94) and CYP2C9-430-CT (AOR = 0.82, 95% CI: 0.68, 0.9... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Subgroup analysis showed a significant relationship between squamous carcinoma (SC), adenocarcinoma ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This data may provide evidence that GSTM 1 gene polymorphisms may be associated with genetic suscept... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Glutathione S-transferase M1 modulates allergen-induced NF-κB activation in asthmatic airway epithel... | DisGeNET | Detail |
| This study demonstrates that the GSTM1 null genotype presents a protective effect against asthma dev... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Patients with urinary bladder neoplasms who had been followed up for a 5-year period were genotyped ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic polymorphisms of glutathione S-transferase M1 and T1, and evaluation of oxidative stress in ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386493716 dbSNP
- Genome
- hg19
- Position
- chr1:110,230,439-110,251,307
- Variant Type
- snv
Genome browser